| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 7,969 | $13.17 | $104,942.43 | -2.4% | +30.1% | +33.7% | |
| Nov 16, 2022 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 385 | $19.29 | $7,426.65 | -0.5% | +36.3% | -74.4% | |
| Nov 16, 2022 | SIBN Si-Bone, Inc. | Pisetsky Michael A68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 3,477 | $13.17 | $45,801.51 | -0.7% | +30.1% | +33.7% | |
| Nov 16, 2022 | ECOR Electrocore, Inc. | Errico Joseph P | Director | Buy | 100,000 | $0.29 | $29,250.00 | +5.1% | -3.8% | +39.0% | |
| Nov 16, 2022 | AVTR Avantor, Inc. | Szlosek Thomas A69 | EVP &CFO | Buy | 12,500 | $20.71 | $258,850.00 | +54.0% | +18.3% | -6.0% | |
| Nov 16, 2022 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 352 | $19.28 | $6,786.56 | -1.1% | +36.3% | -74.4% | |
| Nov 16, 2022 | BLFS Biolife Solutions Inc | Schick Joseph C71 | Director | Sell | 3,000 | $23.85 | $71,550.00 | -12.3% | -0.5% | -47.3% | |
| Nov 16, 2022 | OM Outset Medical, Inc. | Vazquez Martin84 | Chief Operating Officer | Sell | 260 | $19.29 | $5,015.40 | -0.5% | +36.3% | -74.4% | |
| Nov 16, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 2,034 | $2.44 | $4,966.26 | - | - | - | |
| Nov 16, 2022 | OM Outset Medical, Inc. | Williamson Steven S.83 | Chief Commercial Officer | Sell | 3,422 | $19.29 | $66,010.38 | -5.2% | +36.3% | -74.4% | |
| Nov 16, 2022 | OM Outset Medical, Inc. | Racine Jean-Olivier85 | Chief Technology Officer | Sell | 292 | $19.29 | $5,632.68 | -0.7% | +36.3% | -74.4% | |
| Nov 16, 2022 | AVTR Avantor, Inc. | Stubblefield Michael48 | CEO | Buy | 15,000 | $20.95 | $314,250.00 | +3.6% | +18.3% | -6.0% | |
| Nov 16, 2022 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 916 | $19.29 | $17,669.64 | -0.3% | +36.3% | -74.4% | |
| Nov 16, 2022 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 5,464 | $13.19 | $72,076.59 | -0.8% | +30.1% | +33.7% | |
| Nov 16, 2022 | OM Outset Medical, Inc. | Porter Stacey L.89 | Chief People Officer | Sell | 139 | $19.29 | $2,681.31 | -0.2% | +36.3% | -74.4% | |
| Nov 16, 2022 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Senior VP Product Development | Sell | 782 | $1.28 | $1,002.92 | -0.6% | +27.5% | +11.3% | |
| Nov 16, 2022 | TMCI Treace Medical Concepts, Inc. | Timbie Thomas E69 | Director | Sell | 50,000 | $20.14 | $1,006,900.00 | -3.5% | +1.4% | -60.6% | |
| Nov 16, 2022 | AXGN Axogen, Inc. | Mariani Peter J65 | EVP &Chief Financial Officer | Sell | 10,649 | $11.88 | $126,510.12 | -26.4% | -23.6% | -50.6% | |
| Nov 16, 2022 | HYPR Hyperfine, Inc. | Siddiqui Khan54 | CMO And Chief Strategy Officer | Sell | 1,039 | $84.00 | $87,276.00 | -1.2% | +66.3% | +60.2% | |
| Nov 16, 2022 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | President And CEO | Sell | 14,038 | $116.62 | $1,637,168.34 | -2.7% | -2.7% | +37.1% | |
| Nov 16, 2022 | HYPR Hyperfine, Inc. | Gupta Alok | Chief Financial Officer | Sell | 2,227 | $0.84 | $1,870.68 | -1.9% | +66.3% | +60.2% | |
| Nov 16, 2022 | HYPR Hyperfine, Inc. | Paykel Neela | Gen Counsel &Corp Secretary | Sell | 1,895 | $0.84 | $1,591.80 | -1.6% | +66.3% | +60.2% | |
| Nov 15, 2022 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Sell | 50,000 | $20.29 | $1,014,692.47 | -1.2% | +3.8% | -61.3% | |
| Nov 15, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 3,000 | $2.36 | $7,070.12 | +0.2% | - | - | |
| Nov 15, 2022 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 11,280 | $222.07 | $2,504,939.45 | -21.9% | -3.8% | -32.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.